Genetic Polymorphisms Affecting Cardiac Biomarker Concentrations in Children with Cancer: an Analysis from the “European Paediatric Oncology Off-patents Medicines Consortium” (EPOC) Trial-Reference-Cited by-同舟云学术

Genetic Polymorphisms Affecting Cardiac Biomarker Concentrations in Children with Cancer: an Analysis from the “European Paediatric Oncology Off-patents Medicines Consortium” (EPOC) Trial

Published:2020-01-24 Issue:3 Volume:45 Page:413-422
ISSN:0378-7966
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Eur J Drug Metab Pharmacokinet

Author:

Hellmann Farina,Völler Swantje,Krischke Miriam,Jamieson David,André Nicolas,Bisogno Gianni,Boddy Alan,Hempel Georg^ORCID

Funder

Seventh Framework Programme

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s13318-019-00592-6.pdf

Reference41 articles.

1. van Dalen EC, van der Pal JHH, Kremer LCM. Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy. Cochrane Database Syst Rev. 2016;3:CD005008. https://doi.org/10.1002/14651858.cd005008.pub4.

2. van Dalen EC, Raphaël MF, Caron HN, Kremer LCM. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. Cochrane Database Syst Rev. 2014. https://doi.org/10.1002/14651858.cd006647.pub4.

3. Sturgill MG, August DA, Brenner DE. Hepatic enzyme induction with phenobarbital and doxorubicin metabolism and myelotoxicity in the rabbit. Cancer Invest. 2009;18:197–205. https://doi.org/10.3109/07357900009031824.

4. Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991;324:808–15. https://doi.org/10.1056/NEJM199103213241205.

5. Kremer LC, van Dalen EC, Offringa M, Ottenkamp J, Voute PA. Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol. 2001;19:191–6. https://doi.org/10.1200/JCO.2001.19.1.191.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Cardio-oncology;Pediatric Cardiology;2024

2. Association between genetic variants of transmembrane transporters and susceptibility to anthracycline‐induced cardiotoxicity: Current understanding and existing evidence;Clinical Genetics;2023-11-14

3. Pediatric Cardio-Oncology;Pediatric Cardiology;2023

4. Review of potential predictors of anthracycline-induced cardiotoxicity from the position of disease pathogenesis;The Siberian Journal of Clinical and Experimental Medicine;2022-10-19

5. Exploring the role of ferroptosis in the doxorubicin-induced chronic cardiotoxicity using a murine model;Chemico-Biological Interactions;2022-08